---
title: Molecular Characterization and Clinical Relevance of MGMT-Silenced Pancreatic
  Cancer
date: '2024-12-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39618336/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241202180341&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: MGMT silencing occurs in a small subgroup of PACs and is
  enriched in KRAS wild type cases, with a favorable prognostic impact. Our findings
  provide the rationale to explore combinations of alkylating with DNA damaging agents
  in MGMT-silenced ...'
disable_comments: true
---
CONCLUSIONS: MGMT silencing occurs in a small subgroup of PACs and is enriched in KRAS wild type cases, with a favorable prognostic impact. Our findings provide the rationale to explore combinations of alkylating with DNA damaging agents in MGMT-silenced ...